Vertebral osteomyelitis due to Staphylococcus lugdunensis

Journal of Clinical Microbiology

Volumn 34, Issue 4, 1996, Pages 993-994

  Murdoch, David R ^a   Everts, Richard J ^b   Chambers, Stephen T ^b,c   Cowan, Ian A ^b  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; VERTEBRA;

EID: 0029998775     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.4.993-994.1996     Document Type: Article

References (16)

1. Archer, G. L. 1995. Staphylococcus epidermidis and other coagulase-negative staphylococci, p. 1777-1784. In G. L Mandell. J. E. Bennett, and R Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York.
2. De Wit, D., R. Mulla, M. R. Cowie, J. C. Mason, and K. A. Davies. 1993. Vertebral osteomyelitis due to Staphylococcus epidermidis. Br. J. Rheumatol. 32:339-341.
3. Ferguson, K. P., D. W. Lambe, J. L. Keplinger, and J. H. Kalbfleisch. 1991. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can. J. Microbiol. 37:722-724.
4. Fleurette, J., M. Bès, Y. Brun et al. 1989. Clinical isolates of Staphylococcus lugdunensis and 5. schleifen: bacteriological characteristics and susceptibility to antimicrobial agents. Res. Microbiol. 140:107-118.
5. Freney, J., Y. Brun, M. Bes, H. Meugnier, F. Grimont, P. A. D. Grimont, C. Nervi, and J. Fleurette. 1988. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleifen sp. nov., two species from human clinical specimens. Int J. Syst. Bacteriol. 38:168-172.
6. Hébert, A. 1990. Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi. J Clin. Microbiol. 28:2425-2431.
7. Herchline, T. E., and L. W. Ayers. 1991. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol. 29:419-121.
8. Herchline, T. E., J. Barnishan, L. W. Ayers, and R. J. Fass. 1990. Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis Antimicrob. Agents Chemother. 34:2434-2435.
9. Lambe, D. W., K. P. Ferguson, J. L. Keplinger, C. G. Gemmell, and J. H. Kalbfleisch. 1990. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleifen, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can. J. Microbiol. 36:455-63.
10. Ludlam, H., and I. Phillips. 1989. Staphylococcus lugdunensis peritonitis Lancet ii:1394.
11. Palazzo, E., J. Pierre, and N. Besbes. 1992 Staphylococcus lugdunensis arthritis: a complication of arthroscopy. J. Rheumatol. 19:327-328.
12. Paulsson, M., A. Petersson, and Å. Ljungh. 1993. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J. Med Microbiol. 38:96-102.
13. Sturgess, I., F. C. Martin, and S. Eykyn. 1993. Pubic osteomyelitis caused by Staphylococcus simulans. Postgrad. Med J. 69:927-929.
14. Vandenesch, F., J. Etienne, M. E. Reverdy, and S. J. Eykyn. 1993. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect. Dis. 17:871-876.
15. Vandenesch, F., S. J. Projan, B. Kreiswirth, J. Etienne, and R. P. Novick. 1991. Agr-related sequences in Staphylococcus lugdunensis. FEMS Microbiol. Lett. 111:115-122.
16. Vandenesch, F., M. J. Storrs, F. Poitevin-Later, J. Etienne, P. Courvalin, and J. Fleurette. 1991. δ-like haemolysin produced by Staphylococcus lugdunensis. FEMS Microbiol. Lett. 78:65-68.